innovation for industry
Articles ＆ files | Files | Infrastructures | Health ＆ life sciences | Nanomedicine | Nanosciences
The 5,500 sq. m nano-biotechnology platform deploys a full range of medical systems development know-how from sample surface preparation, biological analysis and substrate functionalization to packaging, microfluidics, microsystems, biological detection systems and component readers.
The platform designs devices for 5P medicine: personalized, preventive, predictive, participative, and pertinent. It also develops new technologies for bioproduction, exposome analysis, and the pharmaceutical industry.
Over 150 experts are developing technologies for analyzing living organisms based on the "One Health" approach. They implement sensors, imagers, and actuators to interact with living organisms, as well as microfluidic circuits capable of preparing and characterizing biological samples while minimizing volumes taken.
The platform supports partners ranging from small businesses to major groups as their products reach industrial maturity. It also integrates regulatory frameworks (compliance by design) which are essential to carrying out clinical trials and rapid industrial transfers.
CEA-Leti is part of the Hub4Aim effort, in close collaboration with JBT HubUp, the Grenoble Centre d' Investigation Clinique - Innovation Technologique (CIC-IT) and Grenoble Alpes University.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.